SEGMENTED INFORMATION (Tables)

6 Months Ended

Jun. 30, 2022

SEGMENTED INFORMATION

Schedule of Segmented Revenue and Net Profit/(Loss)

	BioNexus Malaysia			Chemrex			BGLC			Total
	Six months ended June 30, 2022
REVENUE	$	33,467		$	5,480,579		$	-		$	5,514,046
COST OF REVENUE		(58,372	)		(4,878,813	)		-			(4,937,185	)
GROSS (LOSS)/PROFIT		(24,905	)		601,766			-			576,861
OTHER INCOME		4,285			94,945			-			99,230
OPERATING EXPENSES
General and administrative		(51,238	)		(618,348	)		(109,778	)		(779,364	)
FINANCE COSTS		(1,860	)		(3,785	)		-			(5,645	)
(LOSS)/PROFIT BEFORE TAX		(73,718	)		74,578			(109,778	)		(108,918	)
Tax expense		-			(12,678	)		-			(12,678	)
NET (LOSS)/PROFIT	$	(73,718	)	$	61,900		$	(109,778	)	$	(121,596	)

	BioNexus Malaysia			Chemrex			BGLC			Total
	Six months ended June 30, 2021
REVENUE	$	465,470		$	6,075,860		$	-		$	6,541,330
COST OF REVENUE		(358,528	)		(5,132,630	)		-			(5,491,158	)
GROSS PROFIT		106,942			943,230			-			1,050,172
OTHER INCOME		3,848			109,068			-			112,916
OPERATING EXPENSES
General and administrative		(44,128	)		(556,619	)		(80,218	)		(680,265	)
FINANCE COSTS		(2,303	)		(4,534	)		-			(6,837	)
PROFIT/(LOSS) BEFORE TAX		64,359			491,145			(80,218	)		475,286
Tax expense		(654	)		(107,626	)		-			(108,280	)
NET PROFIT/(LOSS)	$	63,705		$	383,519		$	(80,218	)	$	367,006

	As of June 30, 2022 and December 31, 2021
	Total Assets				Total Liabilities
	2022		2021		2022		2021
BGLC & Bionexus	$	1,032,013	$	1,167,214	$	66,334	$	121,586
Chemrex		7,336,700		8,407,176		1,480,732		2,273,025
TOTAL		8,368,713		9,574,390		1,547,066		2,394,611